ベーチェット病(会議録)<br>Adamnatiades-Behcet's Disease (Advances in Experimental Medicine and Biology)

個数:
  • ポイントキャンペーン

ベーチェット病(会議録)
Adamnatiades-Behcet's Disease (Advances in Experimental Medicine and Biology)

  • ウェブストア価格 ¥58,729(本体¥53,390)
  • Kluwer Academic Pub(2003/06発売)
  • 外貨定価 US$ 349.99
  • ウェブストア限定 全点ポイント5倍キャンペーン(6/24~6/28)
  • ポイント 2,665pt
  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合、分割発送となる場合がございます。
    3. 美品のご指定は承りかねます。
  • 【重要:入荷遅延について】
    ウクライナ情勢悪化・新型コロナウィルス感染拡大により、洋書・洋古書の入荷が不安定になっています。詳しくはこちらをご確認ください。
    海外からのお取り寄せの場合、弊社サイト内で表示している標準的な納期よりもお届けまでに日数がかかる見込みでございます。
    申し訳ございませんが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • 製本 Hardcover:ハードカバー版/ページ数 656 p.
  • 言語 ENG
  • 商品コード 9780306477577
  • DDC分類 616.9

基本説明

Presents the state-of-the-art in historical perspectives, epidemiology, diagnostic criteria, prognostic parameters, methods for assessment of disease activity and quality of life, clinical investigation, etiopathology.

Full Description

It is with great pleasure that I write this Foreword to the Proceedings of the International Conference on Behçet's Disease which was held in Berlin in June 2002. This was the first International Conference held under the auspices of the International Society for Behçet's Disease which was founded in 2000 in Seoul. First, I congratulate our colleagues in Berlin, led by Professor Christos Zouboulis of the Department of Dermatology at the Free University of Berlin, for having organised a most successful conference and for having compiled these proceedings so rapidly. It will be realised immediately on scanning the contents of this book that the conference was truly international with 210 participants from 26 countries, as Professor Zouboulis has noted in his preface. These included basic scientists, epidemiologists, pathologists, clinicians and, importantly, representatives from patient organisations. The latter held their own conference alongside the scientific-medical conference to mutual benefit. The combined session of patients and doctors (abstracts on pp 601 – 626) gave the opportunity for an exchange of information and fruitful discussion. The wide ranging scope of the communications is evident from the index and it was most encouraging to see their origin – from all parts of the world, from senior and junior colleagues and, from many different disciplines. Many communications may be regarded as preliminary reports of research in progress and we look forward to seeing the definitive publications in appropriate journals in due course.

Table of Contents

History
Initial Contributions of Adamantiades and 3 (4)
Beh軻t
K. T. Calamia and E. L. Matteson
A Historical Review of Adamantiades-Beh軻t's 7 (10)
Disease
Ch. C. Zouboulis and W. Kietel
Epidemiology
Multicentre Clinical Registries 17 (8)
P. Martus
Epidemiology of Beh軻t's Disease in Asian 25 (6)
Countries and Japan
F. Kaneko, K. Nakamura, M. Sato, M. Tojo,
X. Zheng, and J.-Z. Zhang
Recent Epidemiological Data on Beh軻t's 31 (6)
Disease in Iran
F. Shahram, F. Davatchi, A. Nadji, A.
Jamshidi, H. Chams, C. Chams, N. Shafaie,
M. Akbarian, and F. Gharibdoost
Prevalence of Beh軻t's Disease among Iraqis 37 (6)
Z. S. Al-Rawi and A. H. Neda
Current Epidemiological Data from the German 43 (6)
Registry of Adamantiades-Beh軻ts Disease
Ch.C. Zouboulis, I. K ter, D. Djawari, L.
Krause, U. Pleyer, R. Stadler, W. Kirch, U.
Wollina, P.K. Kohl, W. Keitel, F.R.
Ochsendorf, H.P.M Gollnick, H. Borgmann,
J.R. Turnbull, R. Keitzer, E. H zle, E.
Proksch, R. S nchen, H. Blech, R.
Glosemeyer, G.E. Gross, Y. Hoch, E. G.
Jung, G. Koch, B. Pfeiff, J Reichrath, W.
Schaffartzik, H. Weber, K. Fritz, and C.E.
Orfanos
Heterogenny of Clinical Manifestations in 49 (4)
Beh軻t's Disease among Different Ethnic Groups
A. Yelonakov, Z. Alekberova, and V.
Yasdovsky
Beh軻t's Disease in Patients of German and 53 (6)
Turkish Origin - A Comparative Study
I. K ter, R.. Vonthein, I. G aydin, C.
M ler, L. Kanz, M. Zierhut, and N. St iger
Influence of Sex on Patients with Beh軻t's 59 (6)
Disease in Korea
D. Bang, S. Oh, K-H Lee, E.-S. Lee, and S.
Lee
The Influence of Gender on the Frequency of 65 (2)
Clinical Symptoms in Beh軻t's Disease
F. Davatchi, F. Shahram, C. Chams, H.
Chams, A. Nadji, A. R. Jamshidi, M.
Akbarian, and F. Gharibdoost
The Influence of Gender on the Severity, and 67 (6)
the Outcome of Ocular Lesions in Beh軻t's
Disease
F.D疱atchi, F. Shahram, H. Chams, A. Nadji,
A. R. Jamshidi, C. Chams, M. Akbarian, and
F. Gharibdoost
The Implications of Nonaphthous Beginning of 73 (4)
Beh軻t's Disease
N. Dilsen
Clinical Manifestations and Course of 200 77 (4)
Japanese Patients with Beh軻t's Disease
C. Tanaka, T. Matsuda, E. Hayashi, Y.
Imamura, and S. Ozaki
Clinical Presentation of Beh軻t's Disease in 81 (2)
Internal Medicine
B. Dianati, S. Saliba, G. Etienne, X.
Delbrel, M. Grenouillet, P. Merci  J. L.
Pellegrin, M. Lebras, and M. Longy-Boursier
The Change of Clinical Manifestations of 83 (2)
Patients with Beh軻t's Disease in Japan
S. Kotake, K. Namba, K. Higashi, C. Goda,
T. Ariga, A. Ogawa, and S. Ohno
Chronology of Clinical Manifestations in 85 (6)
Beh軻t's Disease
F. Shahram, K. Assadi, F. Davatchi, A.
Nadji, A. Jamshidi, C. Chams, and M.
Akbarian
General Aspects and Clinical Manifestations 91 (4)
of 100 Iraqi Patients with Beh軻t's Disease
M. M. Al-Waiz, I. Kh. Al-Joofy, R. K.
Muslih, and K. M. Mousawy
The Prevalence of Beh軻t's Syndrome and its 95 (4)
Neurological Complications in Hertfordshire,
U.K.
D. Kidd
Clinical and Genetic Characteristics of 99 (6)
Late-Onset Beh軻t' s Disease
A. Weinberger, T. Klein, and I. Krause
Diagnostic criteria, prognostic parameters,
assessment of disease activity, and quality of
life
The Importance of the Manifestations Besides 105(4)
the Ones Included in International Criteria
for Beh軻t's Disease
N. Dilsen
Influence of Pathergy Test on the Accuracy of 109(4)
Different Diagnosis Criteria for Beh軻t's
Disease
F. Davatchi, F. Shahram, A. Nadji, A. R.
Jamshidi, C. Chams, H. Chams, M. Akbarian,
and F. Gharibdoost
Measuring Health Related Quality of Life 113(10)
M. Bullinger
Univariate and Multivariate Analyses 123(4)
Comparing Demographic, Genetic, Clinical, and
Serological Risk Factors for Severe
Adamantiades-Beh軻t's Disease
Ch. C. Zouboulis, J. R. Turnbull, and P.
Martus
Is Long Term Observation of Patients with 127(4)
Recurrent Aphthous Stomatitis Necessary?
P. Ekmek輅, A. Boyvat, Ozdemir, A. G ler,
and E. G gey
Acetylator Phenotype in Beh軻t's Disease 131(8)
R. A. Najim, K E. Sharquie, and M H.
Al-Janabi
HLA Antigen, Severity and Acetylator 139(4)
Phenotype in Beh軻t's Disease Patients with
Non-Relative Parents
K. E. Sharquie, R. A. Najim, and M. H.
Al-Janabi
Risk Factors of Neuro-Beh軻t 143(4)
H. Houman, I. Ben Ghorbel, A. Braham-Sfaxi,
M. Khanfir, M. Ben Ahmed, M. Lamloum, and
M. Miled
Association of HLA-B51 with Clinical 147(2)
Expression of Behcet's Disease
F. Shahram, F. Davatchi, A. Nadji, A.
Jamshidi, K. Bahar, M. Akbarian, and F.
Gharibdoost
The Beh軻t's Disease Activity Index 149(4)
G. Lawton, M. A. Chamberlain, B. B. Bhakta,
and A. Tennant
Development of Clinical Activity Form for 153(4)
Korean Patients with Beh軻t's Disease
E. -S. Lee, H. S. Kim, D. Bang, H. G. Yu,
H. Chung, D. H. Shin, Y. W. Song, Y. B.
Park, S. K. Lee, S. K. Shin, W. H. Kim, J.
Choi, B. J. Park, and S. Lee
Living with Beh軻t's Disease 157(4)
G. Gilworth, M. A. Chamberlain, B. Bhakta,
A. Tennant, A. Silman, and D. Haskcard
Pathogenesis
Pathogenesis of Adamantiades-Beh軻t's disease 161(12)
Ch. C. Zouboulis, and T. May
Immunopathogenesis and Prevention of Uveitis 173(8)
with the Beh軻t's Disease-Specific Peptide
Linked to Cholera Toxin B
T. Lehner, M R. Stanford, P. A. Phipps, J.
B. Sun, B. G. Xiao, J. Holmgren, T.
Shinnick, A. Hasan, and Y. Mizushima
The Role of Infectious Agents in the 181(4)
Pathogenesis of Beh軻t's Disease
F. Kaneko, M. Tojo, M. Sato, and E. Isogai
Detection of Microbial DNA in Skin Lesions 185(6)
from Patients with Beh軻t's Disease
M. Tojo, H. Yanagihori, X. Zheng, N. Oyama,
E. Isogai, K. Nakamura, and F. Kaneko
Association of Mycoplasma fermentans with 191(4)
Adamantiades-Beh軻t's Disease
Ch. C. Zouboulis, J. R. Turnbull, and P. F.
M丨lradt
Antimicrobial Activity of Synthetic Human CAP 195(6)
18 Peptides to Streptococcus sanguis Isolated
from Patients with Beh軻t's Disease
E. lsogai, M. Hirata, H. Isogai, K. Matuo,
K. Kimura, K. Yokota, K. Oguma, M. Tojo, F.
Kaneko, S. Kotake, and S. Ohno
Anti-Saccharomyces Cerevisiae Antibodies 201(1)
I. Krause, Y. Monselise, G. Milo, and A.
Weinberger
Genetics
The Human Genome Project: what we have Learnt 201(12)
about the MHC Region on Chromosome 6 and its
Potential to Beh軻t's Disease
S. Beck
Comparison of Proteome Map Between Sera of 213(4)
Patients with Beh軻t's Disease and Controls
K.-H. Lee, Kim, S. Lee, and D. Bang
HLA Typing for Class I and Class II Antigens 217(4)
in Iraqi Patients with Beh軻t's Disease
(Sporadic and Familial Cases)
I. Kh. Al-Joofy, R. K Muslih, K M. Mousawy,
and M. M. Al-Waiz
Strong Association of MIC-A *009 of 221(4)
Extracellular Domains and MIC-A*A6 of
Transmembrane Domain in Korean Patients with
Beh軻t's Disease
J. Mok, D. Bang, E.-S. Lee, S. Lee, and K.
Park
MICA Transmembrane Region Polymorphism and 225(4)
HLA B51 in Tunisian Beh軻t's Disease Patients
M. Ben Ahmed, H. Houman, S. Abdelhak, I.
Ben Ghorbel, M. Miled, K. Dellagi, and H.
Louzir
HLA-B51 Frequency in Iranian Patients with 229(2)
Beh軻t's Disease
F. Shahram, F. Davatchi, A. Nadji, N.
Jamshidi, K. Bahar, M. Akbarian, and C.
Chams
Frequency of HLA in Patients with Beh軻t's 231(4)
Disease and Association with Occlusive
Retinal Vasculitis
N. A. Ermakova, Z. S. Alekberova, T. B.
Prokaeva, and I. B. Poljanskaja
The ICAM1469*E is Associated with 235(4)
Susceptibility to Ocular Lesions and
Vasculitis in Korean Patients with Beh軻t's
Disease
E. H. Kim, J. W. Mok, D. Bang, E.-S. Lee,
S. Lee, and K. S. Park
Immunology
Chemokines in Beh軻t's Disease, a Field to Be 239(6)
Explored as a Potential Basis for Therapy
M. Baggiolini
Expression of CCRS in Beh軻t's Disease 245(4)
M. Onder, N. Kokturk, A. Poyraz, and M. O.
Oztas
Immunophenotype and Th1/Th2 Cytokines in 249(6)
Patients with Adamantiades-Beh軻t's Disease
K. Psarra, V. Kapsimali, G. Vaiopoulos, M.
Nikolopoulou, PH. Kaklamanis, G. Palimeris,
E. Kaklamani, and C. Papasteriades
Cytokine Production of Peripheral Blood 255(6)
Mononuclear Cells Stimulated with
Streptococcus Sanguis Antigen in Patients
with Beh軻t's Disease
K. H. Lee, H. S. Kim, F. Kaneko, and D. Bang
Serum Levels of Soluble TNF-a Receptor-II 261(1)
(P75), Circulating yo T-Cells and
Adamantiades-Beh軻t's Disease Activity
A. V. Elezoglou, P. P. Sfikakis, G.
Vaiopoulos, V. Kapsimali, and Ph. G.
Kaklamanis
T-yo Receptor Restriction in Peripheral 261(8)
Lymphocytes of Patients with Beh軻t's Disease
P. M. Van Hagen, H. Hooijkaas, M. W. M. VD
Beemd, G. Verjans, and G.S. Baarsma
Lymphocyte Subsets and Activated Neutrophils 269(4)
in Iraqi Patients with Beh軻t's Disease
K. M. Mousawy, I. Kh. Al-Joofy, R. K.
Muslih, and M. M. Al- Waiz
L-Selectin Expression on Leukocytes of 273(6)
Patients with Beh軻t's Disease
S. H. Assaad-Khalil, M. Abou-Seif, I.
Youssef, and N. Farahat
Autoimmunity to S-Antigen and Retinal 279(4)
Vasculitis in Patients with Beh軻t's Disease
N. A. Ermakova, Z. S. Alekberova, and T. B.
Prokaeva
Nerve Growth Factor in Beh軻t's Disease 283(4)
M. Accorinti, A. Bruscolini, A. Lambiase,
S. Speranza, S. Bonini, and P. Pivetti-Pezzi
Low Serum Mannose-Binding Lectin Levels in 287(6)
Beh軻t's Disease
N. Inanc, E. Birtas, S. Yavuz, T. Ergon,
and H. Direskeneli
Concepts for Research
ISBD Basic Research Perspectives 293(10)
H. Direskeneli and A. G 
Mucocutaneous manifestations
Complex Aphthosis: Evaluation for Beh軻t's 303(8)
Disease?
M. A. McCarty, and J. L. Jorizzo
Complex Aphthosis 311(6)
R. S. Rogers, III
Comparison of Oral Aphthae in Beh軻t's 317(4)
Disease and Idiopathic Recurrent Aphthous
Stomatitis
C. Chams-Davatchi, M. Shizarpour, F.
Davatchi, F. Shahram, H. Chams, A. Nadji,
and A. R. Jamshidi
Bipolar Aphthosis. A Forme Fruste of Beh軻t's 321(2)
Disease
A. Boyvat, P. Ekmek輅, and E. G gey
The Effect of Smoking on the Clinical 323(6)
Features of Adamantiades-Beh軻t's Disease
V. G. Kaklamani, A. Tzonou, N.
Markomichelakis, S. Papazoglou and Ph. G.
Kaklaman﨎
Muco-Cutaneous Lesions of Beh軻t's Disease 329(2)
C. Chams-Davatchi
Dilsen's Pathergy Test in Beh軻t's Disease: 331(2)
Positive Correlation with Clinical
Manifestations
K. E. Sharquie, R. K. Al-Hayani, and R. A.
Najim
Is Beh軻t's Disease a Kobner Positive 333(4)
Disorder?
M. Onder, M. Oztas, and A. Aral
Extensive Pyoderma Gangrenosum-Like Lesion in 337(2)
Two Cases of Beh軻t's Disease, Responding
only to Cyclosporin
C. Chams-Davatchi, M. Shizarpour, F.
Davatchi, F. Shahram, H. Chams, A. Nadji,
and A. R. Jamshidi
A Case of SAPHO Syndrome with Pyoderma 339(4)
Gangrenosum and Inflammatory Bowel Disease
Masquerading as Behcet's Disease
O. Yamasaki, K. Iwatsuki, and F. Kaneko
Cytokine Expression Within Mucocutaneous 343(6)
Lesions of Beh軻t's Disease: Involvement of
Proinflammatory and Thl Cytokines
M. Ben Ahmed, H. Houman, I. Ben Ghorbel, A.
Braham-Sfaxi, M. Miled, K. Dellagi, and H.
Louzir
Ocular Manifestations
Origin and Outcome of Macular Edema in 349(6)
Beh軻t's Disease
H. Chams, A. Lashei, A. Sadeghi-Tari, R.
Karkhaneh, F. Davatchi, F. Shahram, C.
Chams, and A. Abazari
Fluorescein Angiography and Optical Coherence 355(6)
Tomography in Ocular Beh軻t's Disease
L. S. Atmaca, F. Batioglu, and O. M曻t glu
Cells of the Vitreous Body in Beh軻t's Disease 361(4)
T. Ness, and L. L. Hansen
Ocular Lesions Other than Beh軻t's Disease in 365(6)
Beh軻t's Disease-Affected Patients
M. Accorinti, M. P. Pirraglia, R. Corradi,
M. Marino, and P. Pivetti-Pezzi
Neurological manifestations
Neuro-Beh軻t's Disease (Isolated Cerebral 371(1)
Thrombophlebitis Excluded)
A. Sbai, B. Wechsler, P. Duhaut, L. T. H.
Du-Boutin, Z. Amoura, P. Cacoub, P. Godeau,
and J. C. Piette
The Prevalence of Headache in Beh軻t's 371(10)
Syndrome
D. Kidd
Adamantiades-Behcet's Disease and Elevated 381(2)
Intracranial Pressure in a 12 Year Old
Turkish Girl
U. Neudorf, R. Wieland, and J. Schaper
Sensory Symptoms in Beh軻t's Syndrome 383(2)
M. Siepmann, and W. Kirch
Immunohistological Studies in Neuro-Beh軻t's 385(4)
Disease
S. Hirohata, H. Arai, and T. Matsumoto
Soluble Fas Ligand Levels In Cerebrospinal 389(6)
Fluid in Neuro-Beh軻t's Disease
E. Aoyama-Hayashi, T. Matsuda, N. Ohya, C.
Tanaka, M. Kongozi, C. Kamo, M. Hotta, H.
Ikejima, M. Shiraishi, and Y. Mizushima
Cardiovascular Involvement
Beh軻t's Disease With Vascular Involvement: 395(4)
The Contribution of Anticardiolipin
Antibodies and Thrombomodulin
H. Nakano, H. Oka, T. Matsuda, S. Ooka, Y.
Imamura, T. Suzuki, Y. Yamasaki, G. Itoh,
K. Azuma, and S. Ozaki
Arterial Wall Characteristics in Patients 399(6)
with Adamantiades Beh軻t's Disease
A. Protogerou, J. Lekakis, K.
Stamatelopoulos, K. Aznaouridis, E.
Karatzis, I. Ikonomidis, Ch. Papamichael,
N. Markomihelakis, M. Mavrikakis, and Ph.
G. Kaklamanis
The Influence of Plasma Fibrinogen and Serum 405(8)
Ferrum on Blood Viscosity in
Adamantiades-Beh軻t's Disease
S. Mineshita, L.M. Wang, A. Miura, S.
Umetu, Y. Honda, and T. Satoh
Does Hyperhomocysteinemia Increase the Risk 413(6)
of Thrombosis in Beh軻t's Disease?
H. Houman, M. Feki, I. B. Ghorbel, H.
Gadhoum, M. Hsairi, S. Omar, M. Lamloum, N.
Kaabachi, A. Mebazaa, and M. Miled
Pulmonary Artery Involvement in Beh軻t's 419(4)
Disease
A. Akdag K e, M. Kayabali, R. Sarica, E.
Saglik, and G. Azizlerli
Cardiac Manifestation in Four Patients with 423(4)
Adamantiades-Beh軻t's Disease
J. R. Turnbull, A. Tunsch, Y. D. Adler, L.
Lehmann, H. Borgmann, and Ch. C. Zouboulis
Quantitative Evaluation of Microvessels in 427(8)
Beh軻t's Disease
M. Pastorelli, A. L. Pasqui, L. Puccetti,
U. Beermann, F. Biagi, A. Camarri, A.
Palazzuoli, M. Servi, A. Costa, D.
Bischeri, F. Del Santo, F. Gelli, M.
Saletti, F. Bruni, and A. Auteri
18F-FDG-Positron Emission Tomography for 435
Diagnosis of Large Vessel Arteritis in
Beh軻t's Disease
M. Wenger, M. Baltaci, P. Klein-Weigel, E.
Donnemiller, R. Moncayo, and M. Schirmer
Spontaneous Platelet Aggregation in Patients 431(14)
with Beh軻t's Disease by Using Laser-Light
Scattering Aggregometer
H. Nakano, H. Oka, T. Matsuda, S. Ooka, N.
Suzuki, J. Hayashi, S. Ishida, T. Suzuki,
K. Hirota, and S. Ozaki
Various Clinical Manifestations
New Perspectives of Imaging Techniques for 445(4)
Diagnosis of Organ Manifestations in Beh軻t's
Disease
M. Schirmer, A. Klauser, M. Wenger, M.
Baltaci, and R. Moncayo
The Comparison of Ankylosing Spondylitis in 449(6)
Beh軻t's Disease and Normal Population
A. Nadji, F. Davatchi, F. Shahram, A.
Jamshidi, C. Chams, M. Akbarian, F.
Gharibdoost, and K. Mowla
Gastro-Intestinal Manifestations of Beh軻t's 455(4)
Disease
W. Madanat, Z. Sharaiha, S. Khasawneh, H.
Zureikat, and F. Fayyad
Gastrointestinal Disease in Behcet's Disease 459(6)
E. M. Ward, T. A. Woodward, M. Mazlumzadeh,
and K. T. Calamia
Clinical Features of Beh軻t's Disease 465(6)
Patients with Epididymitis
D. Bang, Y.-H. Cho, J. Jung, K.-H. Lee,
E.-S. Lee, and S. Lee
Tonsillectomy and Beh軻t's Disease 471(2)
M. Jalessi, F. Shahram, A. Safavi, F.
Davatchi, A. Nadji, A. Jamshidi, C. Charas,
and F. Gharibdoost
Destructive Sinusopathy and Middle Ear 473(4)
Involvement in Beh軻t's Syndrome
H. M. G. Martins, S. Santos, J. F.
Lourenco, and J. A. Ara仼o
Urine Abnormalities in Beh軻t's Disease 477(4)
F. Shahram, F. Davatchi, A. Nadji, A.
Jamshidi, M. Akbarian, F. Gharibdoost, and
C. Chams
Treatment
Beh軻t's Syndrome: From Aetiology to Treatment 481(6)
R. J. Powell
Treatment of Ocular Manifestations of 487(6)
Beh軻t's Disease
F. Davatchi
The Influence of the Delay of Aggressive 493(2)
Treatment on the Vision and its Outcome in
Beh軻t's Disease
F. Davatchi, F. Shahram, H. Charas, A.
Nadji, A.R. Jamshidi, C. Chams, M.
Akbarian, and F. Gharibdoost
The Clinical Outcome and Treatment in 495(8)
Beh軻t's Disease with Deep Vein Thrombosis
A. Akdag K e, M. Kayabali, R. Sarica, R.
Kaymaz, and G. Azizlerli
The Use of Interferon-a in Beh軻t's Disease - 503(8)
Review of the Literature and Possible
Mechanisms of Action
I. K ter, I. G aydin, M. Treusch, M.
Zierhut, L. Kanz, and N. St iger
Interferon alfa-2a in the Treatment of Ocular 511(10)
Adamantiades-Beh軻t's Disease
L. Krause, J. R. Turnbull, N. Torun, U.
Pleyer, Ch. C. Zouboulis, and M. H. Foerster
Human Recombinant Interferon-a2a (rhIFNa2a) 521(4)
for the Treatment of Beh軻t's Disease with
Sight-Threatening Retinal Vasculitis
I. K ter, M. Zierhut, A. Eckstein, R.
Vonthein, T. Ness, I. G aydin, B.
Grimbacher, S. Blaschke, H.-H. Peter, L.
Kanz, and N. St iger
Beh軻t's Disease: Visual Acuity after 5 Years 525(4)
in Patients with alphaInterferon Treatment
C. M. E. Deuter, I. K ter, I. G aydin, M.
Zierhut, and N. St iger
Multifocal ERG Changes in Patients with 529(4)
Ocular Beh軻t's Disease During Therapy with
Interferon alpha 2a
N. St iger, D. Besch, C. M. E. Deuter, M.
Zierhut, and I. K ter
Influence of Interferon-alpha on Lymphocyte 533
Subpopulations in Beh軻t's Disease
M. Treusch, N St iger, R. Vonthein, M.
Baur, S. Koch, I. G aydin, L. Kanz, M.
Zierhut, and I. K ter
Interferon alpha 2a in IRPB-Derived 531(10)
Peptide-Induced EAU - Part I
N. St iger, I. J. Crane, I. K ten, G. R.
Lamont, M. Zoeller, U. G thert, J. V.
Forrester, M. Zierhut, and R. H. Stiemer
A Case of Beh軻t's Disease with Pathergy 541(4)
Reaction at Interferon Injection Site
A. Aral, M. Onder, and M. Ali G er
Current and Future Use of Anti-TNF Agents in 545(6)
the Treatment of Autoimmune, Inflammatory
Disorders
K. T. Calamia
Successful Long-Term Treatment of Refractory 551(1)
Adamantiades-Beh軻t's Disease (ABD) with
Infliximab: Report of Two Patients
C. G. Katsiari, P. G. Theodossiadis, Ph. G.
Kaklamanis, N. N. Markomichelakis, and P.
P. Sfikakis
The Effect of Anti-Tumour Necrosis Factor 551(10)
Alpha (Infliximab) on Sight-Threatening
Uveitis in a Patient with Beh軻t's Disease
D. S. Morris, M. P. Gavin, and R. D.
Sturrock
Antitumor Necrosis Factor Monoclonal Antibody 561(2)
Therapy in a woman with Severe
Adamantiades-Beh軻t's Disease
F. Behrens, T. Zollner, B. Moeller, J. P.
Kaltwasser, R. Kaufmann, and F. R.
Ochsendorf
Efficacy of Corticosteroids and Cyclosporin 563
in the Treatment of Retinal Vasculitis in
Patients with Beh軻t's Disease
N. A. Ermakova
Enhancement of Transmucosal Permeation of 561(10)
Cyclosporine by Benzalkonium Chloride
P. Van Der Bijl, A. D. Van Eyk, A. A.
Gareis, and I. O. C. Thompson
Azathioprine and Low Dose Pulse 571(4)
Cyclophospha-Mide in Severe Ocular Lesions of
Beh軻t's Disease
F. Shahram, F. Davatchi, H. Chams, A.
Nadji, A. Jamshidi, M. Akbarian, and F.
Gharibdoost
Low Dose MTX for Progressive Neuro-Behcet's 575(4)
Disease
H. Kikuchi, K. Aramaki, and S. Hirohata
High Dose Methotrexate for Ocular Lesions of 579(6)
Behcet's Disease
F. Davatchi, F. Shahram, H. Chams, A. R.
Jamshidi, A. Nadji, C. Chams, M. Akbarian,
and F. Gharibdoost
Therapeutic Effect of Thalidomide through 585(6)
Cytokine and Chemokine Regulation in Herpes
Simplex Virus-Induced Beh軻t's Disease-Like
Animal Model
S. Sohn, E.-S. Lee, S. I. Lee, Y. A. Kim,
H. J. Kwon, D. Bang, and S. Lee
Pentoxifylline Use for Beh軻t's Disease 591(4)
G. C. Liang, and E. M. Chang
Cataract Surgery in Beh軻t's Disease Patients 595(4)
A. Ermakova, and E. A. Egorov
Do Metal Surgical Staples Induce 599(4)
Post-Surgical Intestinal Ulcer in Beh軻t's
Disease?
T. Matsuda, Y. Imamura, A. Shimizu, E.
Hayashi, S. Tsukikawa, M. Enomoto, and T.
Nakagawa
Patient-Physician Relationship
Clinicans, Scientists and Patients 603(2)
C. G. Barnes
Hopes of Patients with Beh軻t's Disease in 605(4)
Japan towards Researchers and the
Relationship between Patients and Medical
Staff Concerning Social Work
T. Nishida, M. Nishida, M. Wakayama, M.
Nishida, and S. Ohno
Jordan Friends of Beh軻t's Disease Patients 609(4)
Society
J. Tamimi, and W. Madanat
The Relationship between Patient Groups and 613(6)
Physicians from a UK Support Group Perspective
G. Seaman, and R. Pearce
"Living With Beh軻t" - A Young Patients' Group 619(2)
A. M ler
Private Practice Offices Serve as Centers for 621(6)
Adamantiades-Beh軻t's Disease
K. Fritz
The Editor 627(2)
Index 629